Quest Diagnostics 2005 Annual Report Download - page 56

Download and view the complete annual report

Please find page 56 of the 2005 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 118

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118

4.5 Form of Acceptance by National City Bank as successor Rights Agent under the Rights
Agreement (filed as an Exhibit to the Company’s 2003 annual report on Form 10-K and
incorporated herein by reference)
4.6 Registration Rights Agreement dated October 31, 2005, among Quest Diagnostics Incorporated
and the Subsidiary Guarantors, Banc of America Securities LLC, Merrill Lynch, Pierce, Fenner
& Smith Incorporated and Morgan Stanley as representatives of the initial purchasers (filed as an
Exhibit to the Company’s current report on Form 8-K (Date of Report: October 31, 2005) and
incorporated herein by reference)
10.1 Form of 6
3
⁄
4
% Senior Notes due 2006, including the form of guarantee endorsed thereon (filed
as an Exhibit to the Company’s current report on Form 8-K (Date of Report: June 27, 2001)
and incorporated herein by reference)
10.2 Form of 7
1
⁄
2
% Senior Notes due 2011, including the form of guarantee endorsed thereon (filed
as an Exhibit to the Company’s current report on Form 8-K (Date of Report: June 27, 2001)
and incorporated herein by reference)
10.3 Form of 5.125% Exchange Senior Note due 2010, including the form of guarantee endorsed
thereon (filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report:
November 1, 2005) and incorporated herein by reference)
10.4 Form of 5.45% Exchange Senior Note due 2015, including the form of guarantee endorsed
thereon (filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report:
November 1, 2005) and incorporated herein by reference)
10.5 Indenture dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and the
Trustee (filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report:
June 27, 2001) and incorporated herein by reference)
10.6 First Supplemental Indenture, dated as of June 27, 2001, among the Company, the Subsidiary
Guarantors, and the Trustee to the Indenture referred to in Exhibit 10.5 (filed as an Exhibit to
the Company’s current report on Form 8-K (Date of Report: June 27, 2001) and incorporated
herein by reference)
10.7 Second Supplemental Indenture, dated as of November 26, 2001, among the Company, the
Subsidiary Guarantors, and the Trustee to the Indenture referred to in Exhibit 10.5 (filed as an
Exhibit to the Company’s current report on Form 8-K (Date of Report: November 26, 2001) and
incorporated herein by reference)
10.8 Third Supplemental Indenture, dated as of April 4, 2002, among Quest Diagnostics, the
Additional Subsidiary Guarantors, and the Trustee to the Indenture referred to in Exhibit 10.5
(filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report: April 1,
2002) and incorporated herein by reference)
10.9 Fourth Supplemental Indenture dated as of March 19, 2003, among Unilab Corporation (f/k/a
Quest Diagnostics Newco Incorporated), Quest Diagnostics Incorporated, The Bank Of New
York, and the Subsidiary Guarantors (filed as an Exhibit to the Company’s quarterly report on
Form 10-Q for the quarter ended March 31, 2003 and incorporated herein by reference)
10.10 Fifth Supplemental Indenture dated as of April 16, 2004, among Unilab Acquisition Corporation
(d/b/a FNA Clinics of America), Quest Diagnostics Incorporated, The Bank Of New York, and
the Subsidiary Guarantors (filed as an Exhibit to the Company’s quarterly report on Form 10-Q
for the quarter ended March 31, 2004 and incorporated herein by reference)
10.11 Sixth Supplemental Indenture dated as of October 31, 2005, among Quest Diagnostics
Incorporated, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the
Company’s current report on Form 8-K (Date of Report: October 31, 2005) and incorporated
herein by reference)
10.12 Seventh Supplemental Indenture dated as of November 21, 2005, among Quest Diagnostics
Incorporated, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the
Company’s current report on Form 8-K (Date of Report: November 21, 2005) and incorporated
herein by reference)
10.13 Amended and Restated Credit Agreement, dated as of April 20, 2004, among the Company, the
Subsidiary Guarantors, the lenders party thereto, and Bank of America, N.A., as Administrative
Agent (filed as an Exhibit to the Company’s quarterly report on Form 10-Q for the quarter
ended March 31, 2004 and incorporated herein by reference)
39